 | • レポートコード：20QY06-03004 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ヒト狂犬病免疫グロブリン（IM）のグローバル市場について種類別（ERIG、HRIG）、用途別（カテゴリーII曝露、カテゴリーIII曝露）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ヒト狂犬病免疫グロブリン（IM）市場の概要 ・世界の主要地域別ヒト狂犬病免疫グロブリン（IM）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒト狂犬病免疫グロブリン（IM）市場規模2015-2026：種類別（ERIG、HRIG） ・世界のヒト狂犬病免疫グロブリン（IM）市場規模2015-2026：用途別（カテゴリーII曝露、カテゴリーIII曝露） ・ヒト狂犬病免疫グロブリン（IM）の北米市場規模2015-2020 ・ヒト狂犬病免疫グロブリン（IM）のヨーロッパ市場規模2015-2020 ・ヒト狂犬病免疫グロブリン（IM）の中国市場規模2015-2020 ・ヒト狂犬病免疫グロブリン（IM）の日本市場規模2015-2020 ・ヒト狂犬病免疫グロブリン（IM）の東南アジア市場規模2015-2020 ・ヒト狂犬病免疫グロブリン（IM）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL Behring、Grifols、Sanofi、Sichuan Yuanda Shuyang、CNBG、Kamada、CBPO、Shuanglin Bio、Weiguang Bio、Shanghai RAAS、Bharat Serum、VINS） ・ヒト狂犬病免疫グロブリン（IM）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒト狂犬病免疫グロブリン（IM）の市場動向・機会・課題 ・調査の結論 |
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient’s passive immunization.
In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. It is given after the wound is cleaned with soap and water or providone-iodine and is followed by a course of rabies vaccine.
Market Analysis and Insights: Global Human Rabies Immunoglobulin (IM) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Rabies Immunoglobulin (IM) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Rabies Immunoglobulin (IM) industry.
Based on our recent survey, we have several different scenarios about the Human Rabies Immunoglobulin (IM) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 324.6 million in 2019. The market size of Human Rabies Immunoglobulin (IM) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Human Rabies Immunoglobulin (IM) Scope and Market Size
The global Human Rabies Immunoglobulin (IM) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Rabies Immunoglobulin (IM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Rabies Immunoglobulin (IM) market is segmented into
ERIG
HRIG
Segment by Application, the Human Rabies Immunoglobulin (IM) market is segmented into
Category II Exposure
Category III Exposure
The Human Rabies Immunoglobulin (IM) market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Rabies Immunoglobulin (IM) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Rabies Immunoglobulin (IM) Market Share Analysis
Human Rabies Immunoglobulin (IM) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Rabies Immunoglobulin (IM) business, the date to enter into the Human Rabies Immunoglobulin (IM) market, Human Rabies Immunoglobulin (IM) product introduction, recent developments, etc.
The major vendors covered:
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
1 Human Rabies Immunoglobulin (IM) Market Overview
1.1 Human Rabies Immunoglobulin (IM) Product Scope
1.2 Human Rabies Immunoglobulin (IM) Segment by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2026)
1.2.2 ERIG
1.2.3 HRIG
1.3 Human Rabies Immunoglobulin (IM) Segment by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Sales Comparison by Application (2020-2026)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Rabies Immunoglobulin (IM) Sales Growth Rate (2015-2026)
1.4.2 Global Human Rabies Immunoglobulin (IM) Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Rabies Immunoglobulin (IM) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Human Rabies Immunoglobulin (IM) Industry Impact
1.5.1 How the Covid-19 is Affecting the Human Rabies Immunoglobulin (IM) Industry
1.5.1.1 Human Rabies Immunoglobulin (IM) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Human Rabies Immunoglobulin (IM) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Human Rabies Immunoglobulin (IM) Players to Combat Covid-19 Impact
2 Human Rabies Immunoglobulin (IM) Estimate and Forecast by Region
2.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Rabies Immunoglobulin (IM) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2015-2020)
2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2015-2020)
2.3 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Rabies Immunoglobulin (IM) Estimates and Projections (2015-2026)
2.4.2 Europe Human Rabies Immunoglobulin (IM) Estimates and Projections (2015-2026)
2.4.3 China Human Rabies Immunoglobulin (IM) Estimates and Projections (2015-2026)
2.4.4 Japan Human Rabies Immunoglobulin (IM) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Rabies Immunoglobulin (IM) Estimates and Projections (2015-2026)
2.4.6 India Human Rabies Immunoglobulin (IM) Estimates and Projections (2015-2026)
3 Global Human Rabies Immunoglobulin (IM) Competition Landscape by Players
3.1 Global Top Human Rabies Immunoglobulin (IM) Players by Sales (2015-2020)
3.2 Global Top Human Rabies Immunoglobulin (IM) Players by Revenue (2015-2020)
3.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2019)
3.4 Global Human Rabies Immunoglobulin (IM) Average Price by Company (2015-2020)
3.5 Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Rabies Immunoglobulin (IM) Players (Opinion Leaders)
4 Global Human Rabies Immunoglobulin (IM) Market Size by Type
4.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Type (2015-2020)
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
4.1.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2014-2020)
4.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2021-2026)
4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Type (2021-2026)
5 Global Human Rabies Immunoglobulin (IM) Market Size by Application
5.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Application (2015-2020)
5.1.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
5.1.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2015-2020)
5.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2021-2026)
5.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Application (2021-2026)
3 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures
3.2 North America Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
3.3 North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
3.4 North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
4 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures
4.2 Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
4.3 Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
4.4 Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
5 China Human Rabies Immunoglobulin (IM) Market Facts & Figures
5.2 China Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
5.3 China Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
5.4 China Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
6 Japan Human Rabies Immunoglobulin (IM) Market Facts & Figures
6.2 Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
6.3 Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
6.4 Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
7 Southeast Asia Human Rabies Immunoglobulin (IM) Market Facts & Figures
7.2 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
8 India Human Rabies Immunoglobulin (IM) Market Facts & Figures
8.2 India Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
8.3 India Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
8.4 India Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Human Rabies Immunoglobulin (IM) Business
12.1 CSL Behring
12.1.1 CSL Behring Human Rabies Immunoglobulin (IM) Corporation Information
12.1.2 CSL Behring Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Products Offered
12.1.5 CSL Behring Recent Development
12.2 Grifols
12.2.1 Grifols Human Rabies Immunoglobulin (IM) Corporation Information
12.2.2 Grifols Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Grifols Human Rabies Immunoglobulin (IM) Products Offered
12.2.5 Grifols Recent Development
12.3 Sanofi
12.3.1 Sanofi Human Rabies Immunoglobulin (IM) Corporation Information
12.3.2 Sanofi Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Human Rabies Immunoglobulin (IM) Products Offered
12.3.5 Sanofi Recent Development
12.4 Sichuan Yuanda Shuyang
12.4.1 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Corporation Information
12.4.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Products Offered
12.4.5 Sichuan Yuanda Shuyang Recent Development
12.5 CNBG
12.5.1 CNBG Human Rabies Immunoglobulin (IM) Corporation Information
12.5.2 CNBG Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CNBG Human Rabies Immunoglobulin (IM) Products Offered
12.5.5 CNBG Recent Development
12.6 Kamada
12.6.1 Kamada Human Rabies Immunoglobulin (IM) Corporation Information
12.6.2 Kamada Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Kamada Human Rabies Immunoglobulin (IM) Products Offered
12.6.5 Kamada Recent Development
12.7 CBPO
12.7.1 CBPO Human Rabies Immunoglobulin (IM) Corporation Information
12.7.2 CBPO Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 CBPO Human Rabies Immunoglobulin (IM) Products Offered
12.7.5 CBPO Recent Development
12.8 Shuanglin Bio
12.8.1 Shuanglin Bio Human Rabies Immunoglobulin (IM) Corporation Information
12.8.2 Shuanglin Bio Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Products Offered
12.8.5 Shuanglin Bio Recent Development
12.9 Weiguang Bio
12.9.1 Weiguang Bio Human Rabies Immunoglobulin (IM) Corporation Information
12.9.2 Weiguang Bio Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Products Offered
12.9.5 Weiguang Bio Recent Development
12.10 Shanghai RAAS
12.10.1 Shanghai RAAS Human Rabies Immunoglobulin (IM) Corporation Information
12.10.2 Shanghai RAAS Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Products Offered
12.10.5 Shanghai RAAS Recent Development
12.11 Bharat Serum
12.11.1 Bharat Serum Human Rabies Immunoglobulin (IM) Corporation Information
12.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Products Offered
12.11.5 Bharat Serum Recent Development
12.12 VINS
12.12.1 VINS Human Rabies Immunoglobulin (IM) Corporation Information
12.12.2 VINS Human Rabies Immunoglobulin (IM) Business Overview and Total Revenue
12.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 VINS Human Rabies Immunoglobulin (IM) Products Offered
12.12.5 VINS Recent Development
13 Human Rabies Immunoglobulin (IM) Manufacturing Cost Analysis
13.1 Human Rabies Immunoglobulin (IM) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
13.4 Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Rabies Immunoglobulin (IM) Distributors List
14.3 Human Rabies Immunoglobulin (IM) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Human Rabies Immunoglobulin (IM) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Human Rabies Immunoglobulin (IM) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Human Rabies Immunoglobulin (IM) Players to Combat Covid-19 Impact
Table 8. Global Market Human Rabies Immunoglobulin (IM) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Region (2015-2020)
Table 10. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2015-2020)
Table 11. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Human Rabies Immunoglobulin (IM) Revenue Share by Region (2015-2020)
Table 13. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Human Rabies Immunoglobulin (IM) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Human Rabies Immunoglobulin (IM) (K Units) of Key Companies (2015-2020)
Table 18. Global Human Rabies Immunoglobulin (IM) Sales Share by Company (2015-2020)
Table 19. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Human Rabies Immunoglobulin (IM) Revenue Share by Company (2015-2020)
Table 21. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2019)
Table 22. Global Human Rabies Immunoglobulin (IM) Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Sites and Area Served
Table 24. Manufacturers Human Rabies Immunoglobulin (IM) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Human Rabies Immunoglobulin (IM) Players
Table 27. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 28. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2015-2020)
Table 29. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Human Rabies Immunoglobulin (IM) Price (K Units) by Type (2015-2020)
Table 31. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2021-2026)
Table 32. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2021-2026)
Table 34. Global Human Rabies Immunoglobulin (IM) Price (K Units) by Type (2021-2026)
Table 35. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2015-2020)
Table 36. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2015-2020)
Table 37. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Human Rabies Immunoglobulin (IM) Price (K Units) by Application (2015-2020)
Table 39. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2021-2026)
Table 40. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2021-2026)
Table 41. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2021-2026)
Table 43. Global Human Rabies Immunoglobulin (IM) Price (K Units) by Application (2021-2026)
Table 44. United States Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2015-2020)
Table 45. United States Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
Table 46. United States Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 47. United States Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 48. United States Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2015-2020)
Table 49. United States Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 50. Europe Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2015-2020)
Table 51. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
Table 52. Europe Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 53. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 54. Europe Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2015-2020)
Table 55. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 56. China Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2015-2020)
Table 57. China Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
Table 58. China Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 59. China Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 60. China Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2015-2020)
Table 61. China Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 62. Japan Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2015-2020)
Table 63. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
Table 64. Japan Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 65. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 66. Japan Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2015-2020)
Table 67. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 74. India Human Rabies Immunoglobulin (IM) Sales (K Units) by Company (2015-2020)
Table 75. India Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2015-2020)
Table 76. India Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2015-2020)
Table 77. India Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 78. India Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2015-2020)
Table 79. India Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 80. CSL Behring Corporation Information
Table 81. CSL Behring Description and Business Overview
Table 82. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 84. CSL Behring Recent Development
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Grifols Human Rabies Immunoglobulin (IM) Product
Table 89. Grifols Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 94. Sanofi Recent Development
Table 95. Sichuan Yuanda Shuyang Corporation Information
Table 96. Sichuan Yuanda Shuyang Description and Business Overview
Table 97. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 99. Sichuan Yuanda Shuyang Recent Development
Table 100. CNBG Corporation Information
Table 101. CNBG Description and Business Overview
Table 102. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. CNBG Human Rabies Immunoglobulin (IM) Product
Table 104. CNBG Recent Development
Table 105. Kamada Corporation Information
Table 106. Kamada Description and Business Overview
Table 107. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Kamada Human Rabies Immunoglobulin (IM) Product
Table 109. Kamada Recent Development
Table 110. CBPO Corporation Information
Table 111. CBPO Description and Business Overview
Table 112. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. CBPO Human Rabies Immunoglobulin (IM) Product
Table 114. CBPO Recent Development
Table 115. Shuanglin Bio Corporation Information
Table 116. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Shuanglin Bio Description and Business Overview
Table 118. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 119. Shuanglin Bio Recent Development
Table 120. Weiguang Bio Corporation Information
Table 121. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Weiguang Bio Description and Business Overview
Table 123. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 124. Weiguang Bio Recent Development
Table 125. Shanghai RAAS Corporation Information
Table 126. Shanghai RAAS Description and Business Overview
Table 127. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 129. Shanghai RAAS Recent Development
Table 130. Bharat Serum Corporation Information
Table 131. Bharat Serum Description and Business Overview
Table 132. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 134. Bharat Serum Recent Development
Table . VINS Corporation Information
Table . VINS Description and Business Overview
Table . VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . VINS Human Rabies Immunoglobulin (IM) Product
Table . VINS Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Human Rabies Immunoglobulin (IM) Distributors List
Table 143. Human Rabies Immunoglobulin (IM) Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Product Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Rabies Immunoglobulin (IM) Market Share by Application in 2020 & 2026
Figure 6. Category II Exposure Examples
Figure 7. Category III Exposure Examples
Figure 8. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Human Rabies Immunoglobulin (IM) Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Human Rabies Immunoglobulin (IM) Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Human Rabies Immunoglobulin (IM) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Human Rabies Immunoglobulin (IM) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue in Human Rabies Immunoglobulin (IM) 2015 & 2019
Figure 26. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2015-2020)
Figure 28. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2015-2020)
Figure 30. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 32. United States Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 33. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2019
Figure 34. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 35. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2019
Figure 36. China Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2019
Figure 37. China Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 38. China Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2019
Figure 39. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2019
Figure 40. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 41. Japan Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2019
Figure 42. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2019
Figure 43. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 44. Southeast Asia Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2019
Figure 45. India Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2019
Figure 46. India Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 47. India Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2019
Figure 48. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Kamada Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. CBPO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Shuanglin Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Weiguang Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bharat Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. VINS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Human Rabies Immunoglobulin (IM)
Figure 62. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 63. Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
ヒト狂犬病免疫グロブリン（IM）の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Human Rabies Immunoglobulin (IM) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.9% in the forecast period of 2020 to 2025 and will expected to reach USD 420.7 million by 2025, from USD 334 million in 2019. The…- ヒト免疫グロブリンの世界市場レポート2020 Market Analysis and Insights: Global Human Immunoglobulin Market The global Human Immunoglobulin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Human Immunoglobulin Scope and Market Size The global Human…
- 静脈内免疫グロブリン（IVIg）の世界市場レポート2020 Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin. North America regi…
- 免疫グロブリンELISAキットの世界市場レポート2020 Market Analysis and Insights: Global Immunoglobulin ELISA Kits Market The global Immunoglobulin ELISA Kits market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Immunoglobulin ELISA Kits Scope and Market Size T…
- ヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Endostatin market repo…